Key Terms Sitemap
- 10 U.S.C. § 331
- 10 U.S. Code § 1107 - Notice of Use of an Investigational New Drug or a Drug Unapproved for its Applied Use
- 11 U.S.C. § 101(5)
- 11 U.S.C. § 105(a)
- 11 U.S.C. § 108(b)
- 11 U.S.C. § 1104(a)
- 11 U.S.C. § 1113
- 11 U.S.C. § 1121
- 11 U.S.C. § 1122
- 11 U.S.C. § 1125(b)
- 11 U.S.C. § 1126(c)
- 11 U.S.C. § 1126(e)
- 11 U.S.C. § 1129(a)
- 11 U.S.C. § 1129(a)(10)
- 11 U.S.C. § 1129(a)(11)
- 11 U.S.C. § 1129(b)
- 11 U.S.C. § 1129(b)(2)(A)(i)
- 11 U.S.C. §1129(b)(2)(A)(iii)
- 11 U.S.C. § 1129(b)(2)(B)
- 11 U.S.C. § 1129(b)(2)(B)(ii)
- 11 U.S.C. § 1322(b)(1)
- 11 U.S.C. § 1322(b)(2)
- 11 U.S.C. § 1325(a)(3)
- 11 U.S.C. § 1325(a)(5)(B)
- 11 U.S.C. § 1325(a)(5)(C)